Table 1.
Drug | Active metab | Bioavail (%) | Food effect | Half-life (hrs) | Protein binding (%) | Route of elimination (%) | |||
Drug | Metab | Drug | Metab | Renal | Hepatic | ||||
Losartan | Yes | 33 | No | 2 | 6–9 | 98.7 | 99.8 | 35 | 60 |
Valsartan | No | 25 | Yes | 9 | — | 95 | — | 13 | 83 |
Irbesartan | No | 70 | No | 11–15 | — | 90–95 | — | 20 | 80 |
Candesartan | Yes | 42 | No | 3.5–4.0 | 3–11 | 99.5 | — | 33 | 67 |
Telmisartan | No | 43 | No | 24 | — | >99 | — | 0.5 | >97 |
Eprosartan | No | 15 | No | 5–7 | — | 98 | — | 7 | 90 |
Olmesartan | Yes | 26 | No | ˜13 | — | >99 | — | 35–50 | 50–65 |